Preventive or therapeutic agent for kidney disease Grant US-11253571-B2 United States of America 22 Feb 2022
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as… Grant US-11059796-B2 United States of America 13 Jul 2021
Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and… Grant US-10913779-B2 United States of America 09 Feb 2021
A2/NY-ESO-1 SPECIFIC T CELL RECEPTORS AND USES THEREOF Application WO-2020188348-A2 World Intellectual Property Organisation (WIPO) 24 Sep 2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as… Grant US-10611740-B2 United States of America 07 Apr 2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan… Grant US-10532088-B2 United States of America 14 Jan 2020
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the… Grant US-10442798-B2 United States of America 15 Oct 2019
Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of… Grant US-10421751-B2 United States of America 24 Sep 2019
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the… Grant US-10364237-B2 United States of America 30 Jul 2019
Preventive or therapeutic agent for kidney disease Application US-10349640-B2 United States of America 16 Jul 2019
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ… Grant US-10208061-B2 United States of America 19 Feb 2019
Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of… Grant US-10189777-B2 United States of America 29 Jan 2019
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the… Grant US-9896441-B2 United States of America 20 Feb 2018
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of… Grant US-9802958-B2 United States of America 31 Oct 2017